Name | KARDIOFARM, OOO |
|---|
INN | 3441032160 |
|---|
KPP | 344401001 |
|---|
OGRN | 1073459005619 |
|---|
OKPO | 81995849 |
|---|
Address | 400087, Volgogradskaya Oblast', g. Volgograd, ul. Novorossiyskaya, d. D. 65 |
|---|
Phone | +7 (904) 417-46-67 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores | | All types of activities | | 90.04 | Additional activity | Operation of arts and entertainment |
Registration date | 26.06.2007 |
|---|
Registering department | Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N 9 po Volgogradskoy oblasti |
|---|
|
KARDIOFARM, OOO (Volgograd Oblast; INN 3441032160) was registered on 26 Jun 2007. The company's authorized capital as of July 1, 2012 was 20000 rub. Type of ownership of KARDIOFARM, OOO - Limited liability companies. Form of ownership of KARDIOFARM, OOO - Private property. Principal activities of KARDIOFARM, OOO: retailing drugs in specialized stores (pharmacies) (47.73), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74), retailing of cosmetics and personal hygiene products in specialized stores (47.75). |
Economic indicators2023
Net profit (RAS) of KARDIOFARM, OOO dropped in 2023 by 5.29% to 3.80 million RUB from 4.01 million RUB over the same period in 2022, the company informed. Revenue decreased in the accounting period by 6.70% to 24.33 million RUB from 26.07 million RUB in 2022; cost of goods sold decreased by 7.01% to 19.86 million RUB from 21.36 million RUB; sales profit fell by 5.30% to 4.47 million RUB from 4.72 million RUB. 2022
Net profit (RAS) of KARDIOFARM, OOO grew over 2022 by 23.16% to 4.01 million RUB from 3.26 million RUB over 2021, the company informed. Revenue increased in the accounting period by 6.60% to 26.07 million RUB from 24.46 million RUB over 2021; cost of goods sold grew by 3.52% to 21.36 million RUB from 20.63 million RUB; sales profit went up by 23.19% to 4.72 million RUB from 3.83 million RUB. 2021
Net profit (RAS) of KARDIOFARM, OOO grew over 2021 2.72 times to 3.26 million RUB from 1.20 million RUB over 2020, the company informed. Revenue decreased in the accounting period by 2.62% to 24.46 million RUB from 25.12 million RUB in 2020; cost of goods sold decreased by 13.42% to 20.63 million RUB from 23.83 million RUB; sales profit went up 2.97 times to 3.83 million RUB from 1.29 million RUB. 2020
Net profit (RAS) of KARDIOFARM, OOO grew over 2020 by 9.71% to 1.20 million RUB from 1.09 million RUB over 2019, the company informed. Revenue decreased in the accounting period by 5.84% to 25.12 million RUB from 26.68 million RUB in 2019; cost of goods sold decreased by 6.60% to 23.83 million RUB from 25.51 million RUB; sales profit went up by 10.93% to 1.29 million RUB from 1.16 million RUB. 2019
Net profit (RAS) of KARDIOFARM, OOO grew over 2019 8.95 times to 1.09 million RUB from 122.00 thousand RUB over 2018, the company informed. Revenue decreased in the accounting period by 16.69% to 26.68 million RUB from 32.02 million RUB in 2018; cost of goods sold decreased by 19.52% to 25.51 million RUB from 31.70 million RUB; sales profit went up 3.63 times to 1.16 million RUB from 320.00 thousand RUB. 2018
Net profit (RAS) of KARDIOFARM, OOO dropped in 2018 3.95 times to 122.00 thousand RUB from 482.00 thousand RUB over the same period in 2017, the company informed. Revenue increased in the accounting period by 6.92% to 32.02 million RUB from 29.95 million RUB over 2017; cost of goods sold grew by 8.05% to 31.70 million RUB from 29.34 million RUB; sales profit fell by 47.45% to 320.00 thousand RUB from 609.00 thousand RUB. 2017
Net profit (RAS) of KARDIOFARM, OOO grew over 2017 25.37 times to 482.00 thousand RUB from 19.00 thousand RUB over 2016, the company informed. Revenue increased in the accounting period by 17.80% to 29.95 million RUB from 25.42 million RUB over 2016; cost of goods sold grew by 15.72% to 29.34 million RUB from 25.35 million RUB; sales profit went up 8.83 times to 609.00 thousand RUB from 69.00 thousand RUB. 2016
Net profit (RAS) of KARDIOFARM, OOO grew over 2016 by 26.67% to 19.00 thousand RUB from 15.00 thousand RUB over 2015, the company informed. Revenue increased in the accounting period by 0.50% to 25.42 million RUB from 25.30 million RUB over 2015; cost of goods sold grew by 0.55% to 25.35 million RUB from 25.22 million RUB; sales profit fell by 14.81% to 69.00 thousand RUB from 81.00 thousand RUB. 2014
Net profit (RAS) of KardioFarm, OOO dropped in 2014 20.00 times to 14.00 thousand RUB from 280.00 thousand RUB over the same period in 2013, the company informed. Revenue decreased in the accounting period by 12.34% to 39.05 million RUB from 44.55 million RUB in 2013; cost of goods sold decreased by 11.76% to 38.95 million RUB from 44.14 million RUB; sales profit fell 3.88 times to 107.00 thousand RUB from 415.00 thousand RUB. 2013
Net profit (RAS) of KardioFarm, OOO dropped in 2013 by 48.53% to 280.00 thousand RUB from 544.00 thousand RUB over the same period in 2012, the company informed. Revenue increased in the accounting period by 26.60% to 44.55 million RUB from 35.19 million RUB over 2012; cost of goods sold grew by 27.92% to 44.14 million RUB from 34.50 million RUB; sales profit fell by 39.68% to 415.00 thousand RUB from 688.00 thousand RUB. 2012
Net profit (RAS) of KardioFarm, OOO dropped in 2012 2.29 times to 544.00 thousand RUB from 1.25 million RUB over the same period in 2011, the company informed. Revenue decreased in the accounting period by 1.82% to 35.19 million RUB from 35.84 million RUB in 2011; cost of goods sold remained at the same level amounting to 34.50 million RUB compared to 34.47 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|